https://ipharmag.com/article/pfizer-expands-cost-cutting-plan-2026 iPharmag en 2026-08-04T19:39:28+00:00 Pfizer Deepens Cost Cuts Toward $6.7 Billion as Pandemic Revenue Fades https://ipharmag.com/article/hpv-chewing-gum-oral-cancer-prevention iPharmag en 2026-08-04T19:39:28+00:00 A Bean-Based Chewing Gum Cut Oral HPV by Up to 93% in Lab Tests https://ipharmag.com/article/ai-brain-aging-maps-mri-neurodegeneration iPharmag en 2026-08-04T19:39:28+00:00 AI Turns Brain MRIs Into Region-by-Region ‘Aging Maps’ to Study Dementia https://ipharmag.com/article/vertex-sionna-cystic-fibrosis-competition iPharmag en 2026-08-04T19:39:28+00:00 Vertex Beats Estimates, but a Rival 50 Times Smaller Looms Over Its Cystic Fibrosis Empire https://ipharmag.com/article/fda-breakthrough-olomorasib-pancreatic-cancer iPharmag en 2026-08-04T19:39:28+00:00 FDA Grants Breakthrough Status to Lilly’s Olomorasib in KRAS-Mutant Pancreatic Cancer https://ipharmag.com/article/brain-defends-body-weight-regain iPharmag en 2026-08-04T06:47:40+00:00 Why the Brain Fights to Regain Lost Weight — and What It Means for Obesity Drugs https://ipharmag.com/article/supernus-indivior-cns-pharma-merger iPharmag en 2026-08-04T06:47:40+00:00 Supernus and Indivior to Merge, Creating a $2.2B CNS-Focused Drugmaker https://ipharmag.com/article/vanderbilt-taok-alzheimers-tool-compounds iPharmag en 2026-08-04T06:47:40+00:00 New Chemical Tools Let Scientists Probe a Little-Understood Alzheimer’s Protein https://ipharmag.com/article/astrazeneca-bristol-myers-megamerger-rumors iPharmag en 2026-08-04T06:47:40+00:00 AstraZeneca Shares Slide on Reports of a Possible $400B Bristol Myers Megamerger https://ipharmag.com/article/phage-therapy-fmt-recurrent-uti-case-series iPharmag en 2026-08-04T06:47:40+00:00 Combining Phage Therapy and Fecal Transplants Cut Recurrent UTIs in a First Human Case Series https://ipharmag.com/article/apnimed-ipo-oral-sleep-apnea-drug iPharmag en 2026-08-03T10:17:00+00:00 Apnimed Raises $192M in IPO for What Could Be the First Oral Sleep Apnea Drug https://ipharmag.com/article/cancer-super-enhancers-dna-breaks-mutations iPharmag en 2026-08-03T10:17:00+00:00 Cancer May Break Its Own DNA to Keep Growing, Study Finds https://ipharmag.com/article/myeloproliferative-neoplasm-genetic-early-warning iPharmag en 2026-08-03T10:17:00+00:00 Blood Cancer’s Genetic Warning Signs Can Appear Years Early, Study Shows https://ipharmag.com/article/ratio-therapeutics-70m-radiopharmaceutical-funding iPharmag en 2026-08-03T10:17:00+00:00 Ratio Therapeutics Raises $70M to Push Its Targeted Cancer Radiotherapies